Yonker is a co-inventor on a patent for zonulin antagonists to treat MIS-C, as are two other co-authors. Co-authors also ...

COVID-19 can trigger serious brain and nerve problems, including stroke, seizures, and memory loss, even weeks after recovery ...

The FDA has missed the date for Coya Therapeutics’ investigational new drug (IND) application, citing a lack of resources and ...

School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom ...

An international research team has identified a new protein that specifically transports enzymes into peroxisomes. Its mode ...

The immune system senses damage to cell membranes caused by pore-forming proteins and mounts a response. The sneezing, itchy ...

Maryland-based biotech NextCure is looking for partners to advance a candidate for the currently incurable rare disease ...

Long COVID affects lean and obese individuals differently, causing lasting metabolic and physiological changes—even after mild infection-in a primate model ...

Regulators block Duchenne muscular dystrophy treatment after fatal side-effects outweigh questionable efficacy ...

Specifically, the researchers found that intersectin keeps tiny, message-carrying bubbles inside brain cells in a particular ...